Arch Point Investors Johnson & Johnson Transaction History

Arch Point Investors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $589,103 - $653,631	-3,778 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $610,147 - $678,037	3,778 New	3,778 $610,000
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $990,051 - $1.06 Million	-6,208 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $2,296 - $2,557	-15 Reduced 0.24%	6,208 $1.02 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $43,938 - $48,148	313 Added 5.3%	6,223 $926,000
Q2 2020 Jul 31, 2020	BUY	$128.81 - $155.51 $134,606 - $162,507	1,045 Added 21.48%	5,910 $831,000
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $232,838 - $322,609	2,095 Added 75.63%	4,865 $638,000
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $332,137 - $381,476	2,605 Added 1578.79%	2,770 $404,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $21,362 - $22,337	165	165 $21,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.